IRIS
CITRARO, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.223
AS - Asia 2.809
EU - Europa 1.713
SA - Sud America 595
AF - Africa 80
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 8
Totale 9.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.995
SG - Singapore 1.252
IT - Italia 748
CN - Cina 610
BR - Brasile 458
VN - Vietnam 283
DE - Germania 272
IN - India 260
CA - Canada 174
GB - Regno Unito 160
FI - Finlandia 146
HK - Hong Kong 117
SE - Svezia 114
NL - Olanda 50
AR - Argentina 46
ID - Indonesia 35
MX - Messico 35
AU - Australia 34
FR - Francia 30
JP - Giappone 29
IQ - Iraq 27
TR - Turchia 27
BD - Bangladesh 26
ES - Italia 26
ZA - Sudafrica 26
RU - Federazione Russa 25
CO - Colombia 22
EC - Ecuador 22
UA - Ucraina 21
PK - Pakistan 18
UZ - Uzbekistan 18
PL - Polonia 16
CL - Cile 15
SA - Arabia Saudita 15
IL - Israele 14
CZ - Repubblica Ceca 13
RO - Romania 13
GR - Grecia 12
VE - Venezuela 12
IR - Iran 11
PH - Filippine 11
EG - Egitto 9
MA - Marocco 9
AT - Austria 8
CH - Svizzera 8
PY - Paraguay 8
KR - Corea 7
MT - Malta 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
HR - Croazia 6
KE - Kenya 6
TN - Tunisia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DO - Repubblica Dominicana 5
EE - Estonia 5
KZ - Kazakistan 5
MY - Malesia 5
PE - Perù 5
PT - Portogallo 5
JO - Giordania 4
NG - Nigeria 4
TW - Taiwan 4
UY - Uruguay 4
AF - Afghanistan, Repubblica islamica di 3
AO - Angola 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
HN - Honduras 3
IE - Irlanda 3
JM - Giamaica 3
LK - Sri Lanka 3
LT - Lituania 3
NP - Nepal 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
CY - Cipro 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
GD - Grenada 1
GH - Ghana 1
Totale 9.452
Salva come PNG Salva come JPEG
Città #
San Jose 654
Singapore 497
Chandler 430
Ashburn 353
Dallas 341
Munich 230
Santa Clara 203
Bengaluru 169
Hefei 166
Milan 157
Princeton 129
Lawrence 128
Catanzaro 118
Beijing 113
Hong Kong 110
Ottawa 100
Ho Chi Minh City 98
Chicago 91
London 91
Wilmington 76
Turku 69
Helsinki 68
Hanoi 52
Boardman 48
New York 48
Des Moines 44
Los Angeles 42
São Paulo 42
Catania 41
Redwood City 31
Orem 28
Brooklyn 26
Amsterdam 24
Montreal 24
Tokyo 23
Haiphong 21
Rome 21
Chennai 18
Shanghai 18
Rio de Janeiro 17
Guangzhou 16
Johannesburg 16
Palermo 16
Tashkent 16
Atlanta 15
Council Bluffs 15
Da Nang 15
Florence 15
Toronto 15
Boston 14
Melbourne 14
Norwalk 14
The Dalles 14
San Nicola Manfredi 13
Mexico City 12
Shenzhen 12
Stockholm 12
Warsaw 12
Olomouc 11
Brasília 10
Istanbul 10
Messina 10
Naples 10
Phoenix 10
Sydney 10
Bari 9
Dhaka 9
Prato 9
Riyadh 9
Hải Dương 8
Madrid 8
Padova 8
Pune 8
Salvador 8
San Francisco 8
West Jordan 8
Ankara 7
Aversa 7
Baghdad 7
Biên Hòa 7
Bogotá 7
Boydton 7
Bắc Giang 7
Campinas 7
Can Tho 7
Charlotte 7
Columbus 7
Curinga 7
Curitiba 7
Guayaquil 7
Jakarta 7
Newark 7
Nuremberg 7
Porto Alegre 7
Tel Aviv 7
Vienna 7
Assago 6
Augusta 6
Belo Horizonte 6
Bologna 6
Totale 5.542
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 247
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 230
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 132
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 118
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 109
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 101
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 101
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 97
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 97
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 91
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 90
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 85
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 85
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 85
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 84
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 83
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 83
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 82
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 80
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 80
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 80
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 79
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 78
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 77
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 77
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 77
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 76
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 76
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 73
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 72
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 72
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 70
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 69
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 69
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 69
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 69
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 69
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 69
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 68
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 68
Vasostatin-1 restores autistic disorders in an idiopathic autism model (BTBR T+ Itpr3tf/J mice) by decreasing hippocampal neuroinflammation 67
The potential role of cannabinoids in epilepsy treatment. 67
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 67
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 67
Pharmacokinetic considerations about antiseizure medications in the elderly 66
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 66
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 66
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 65
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells (CO-FIRST AUTHOR) 65
A questionnaire-based study on prevalence and treatments of headache in Secondary Schools people of Catanzaro 64
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  63
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 63
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 63
Long-Term High-Fat Diet Aggravates Absence Seizures and Neurobehavioral Disorders Without Inducing Metabolic Disorders in WAG/Rij Rats: Involvement of Systemic and Central Inflammation 61
Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real-Life Clinical Cross-Sectional Observational Study 61
Microbiota-gut brain axis involvement in neuropsychiatric disorders 61
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 61
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 61
Epidemiology and outcomes of status epilepticus 60
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 58
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 58
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures. Expert Opin Pharmacother. 2014 Jan 17. [Epub ahead of print] PubMed PMID: 24437529. 58
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats 58
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 57
Nano‐hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study 57
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 57
A Multiple Synergic Treatment for Non-Healing Ulcer Management in a Patient with Klippel–Trenaunay Syndrome 56
Antidepressants drugs for seizures and epilepsy: Where do we stand? 56
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis 56
Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence 56
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists 55
Colchicine in Managing Skin Conditions: A Systematic Review 55
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 54
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity 54
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 54
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy 54
Immediate and controlled-release pregabalin for the treatment of epilepsy 54
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 54
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis 54
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 53
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region 53
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders 53
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 53
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis 53
Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats 53
Statins and Epilepsy: Preclinical Studies, Clinical Trials and Statin-Anticonvulsant Drug Interactions 53
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 53
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 52
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence 52
Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs 52
Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists 52
Direct Modulation of High-Frequency Neural Oscillations in the Auditory Cortex Through Electrical Microstimulation Generated by PVDF Sensors 52
Corrigendum to "Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice)" (DOI:10.1016/j.neuropharm.2005.04.012) 52
Pharmacovigilance in pharmaceutical companies: An overview 51
Biomimetic Sonar for Electrical Activation of the Auditory Pathway 51
Oxygen–Ozone Therapy in Cervicobrachial Pain: A Real-Life Experience 50
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis 50
mTOR inhibition modulates epileptogenesis, seizures and depressive-like behavior in a genetic model of absence seizures and mild depression comorbidity: a role for inflammatory responses 50
Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy? 50
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 50
Totale 7.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.205
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 11 16 5
2021/2022435 3 6 9 92 21 14 7 84 79 50 58 12
2022/20231.248 263 101 48 109 120 102 15 81 191 86 91 41
2023/2024734 120 90 63 61 54 121 31 46 11 47 29 61
2024/20252.141 262 71 105 90 143 262 161 94 237 71 266 379
2025/20264.603 303 448 556 674 512 244 653 256 636 321 0 0
Totale 9.736